Monday, January 7, 2019

Sanofi to pay Regeneron $462 million in revised immuno-oncology deal

Sanofi will pay Regeneron some $462 million in a revision of their deal in immuno-oncology, a growing sector in healthcare research which aims to help the body's own immune system fight cancer.


from Reuters: Health News https://reut.rs/2sd1wDk
via IFTTT

0 comments:

Post a Comment